TB
Theravance Biopharma, Inc. (TBPH)
NASDAQ·Healthcare·Biotechnology
$16.77
-0.24%
Mkt Cap $847.57M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $56.59M | $45.89M | -18.90% | $0.44 | $0.06 | -86.36% | — | — |
| Q4 2025 Nov 10, 2025 | $43.09M | $19.99M | -53.61% | -$0.03 | $0.04 | +233.33% | — | — |
| Q3 2025 Aug 12, 2025 | $18.73M | $26.20M | +39.87% | -$0.14 | -$0.08 | +42.86% | — | — |
| Q2 2025 May 8, 2025 | $16.10M | $15.39M | -4.42% | -$0.11 | -$0.17 | -54.55% | — | — |
| Q1 2025 Feb 26, 2025 | $17.09M | $18.75M | +9.72% | -$0.05 | -$0.05 | +0.00% | — | — |
| Q4 2024 Nov 12, 2024 | $27.32M | $16.87M | -38.25% | -$0.10 | -$0.06 | +40.00% | — | — |
| Q3 2024 Aug 5, 2024 | $15.45M | $14.26M | -7.73% | -$0.09 | -$0.13 | -44.44% | — | — |
| Q2 2024 May 13, 2024 | $13.96M | $14.50M | +3.89% | -$0.19 | -$0.09 | +52.63% | — | — |
| Q1 2024 Feb 26, 2024 | $17.68M | $17.57M | -0.65% | $0.04 | $0.03 | -14.36% | — | — |
| Q4 2023 Nov 7, 2023 | $17.68M | $15.69M | -11.24% | -$0.10 | -$0.01 | +90.00% | — | — |
| Q3 2023 Aug 7, 2023 | $15.40M | $13.75M | -10.72% | -$0.16 | -$0.13 | +18.75% | — | — |
| Q2 2023 May 8, 2023 | $13.84M | $10.42M | -24.73% | -$0.27 | -$0.24 | +11.11% | — | — |
| Q1 2023 Feb 27, 2023 | $15.40M | $14.65M | -4.90% | -$0.20 | -$0.21 | -5.00% | — | — |
| Q4 2022 Nov 7, 2022 | $11.81M | $12.45M | +5.43% | -$0.22 | -$0.21 | +4.55% | — | — |
| Q3 2022 Aug 4, 2022 | $12.49M | $11.05M | -11.56% | -$0.06 | -$0.04 | +33.33% | — | — |
| Q2 2022 May 5, 2022 | $14.40M | $13.20M | -8.34% | -$0.12 | -$0.24 | -100.00% | — | — |
| Q1 2022 Feb 23, 2022 | $13.49M | $14.95M | +10.81% | -$0.30 | -$0.43 | -43.33% | — | — |
| Q4 2021 Nov 3, 2021 | $16.10M | $13.19M | -18.05% | -$0.60 | -$0.48 | +20.00% | — | — |
| Q3 2021 Aug 3, 2021 | $12.91M | $12.91M | +0.00% | -$0.96 | -$0.80 | +16.67% | — | — |
| Q2 2021 May 4, 2021 | $11.68M | $14.26M | +22.09% | -$1.05 | -$1.24 | -18.10% | — | — |